92 related articles for article (PubMed ID: 15080494)
1. HCC CKs are altered histones during tumor transformation in hepatoma.
Liu YH; Pei RJ; Cheng CC; Ho HC; Ho CC; Yeh KT; Lee KY; Lai YS
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):27-38. PubMed ID: 15080494
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
3. Possible relation between histone 3 and cytokeratin 18 in human hepatocellular carcinoma.
Ho CC; Cheng CC; Liu YH; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
In Vivo; 2008; 22(4):457-62. PubMed ID: 18712172
[TBL] [Abstract][Full Text] [Related]
4. Could the cytokeratin molecule be modulated during tumor transformation in hepatocellular carcinoma?
Su B; Pei RJ; Yeh KT; Hsu YH; Lai YS
Pathobiology; 1994; 62(3):155-9. PubMed ID: 7524530
[TBL] [Abstract][Full Text] [Related]
5. The expression of cytokeratin 18 in transitional cell carcinoma comparing with hepatoma.
Yeh CC; Pei RJ; Liu YH; Su B; Lee KY; Yeh KT; Hsu YH; Ho CC; Ho HC; Lai YS
Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):3-10. PubMed ID: 10850364
[TBL] [Abstract][Full Text] [Related]
6. The stability of cytokeratin 18 in human liver cells during colchicine-induced microtubule disruption.
Liu Y; Su B; Pei R; Yeh C; Yeh K; Ying Lee K; Hsu Y; Ho C; Lai Y
Food Chem Toxicol; 2001 Jan; 39(1):85-9. PubMed ID: 11259854
[TBL] [Abstract][Full Text] [Related]
7. Do the CK18 related proteins change in general in epithelial cancers?
Pei RJ; Liu YH; Su B; Yeh CC; Lee KY; Yeh KT; Hsu YH; Ho CC; Lai YS
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):253-60. PubMed ID: 11913716
[TBL] [Abstract][Full Text] [Related]
8. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
9. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
11. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of histone variant H2A.1 and cellular transformation are related in N-nitrosodiethylamine-induced sequential hepatocarcinogenesis.
Khare SP; Sharma A; Deodhar KK; Gupta S
Exp Biol Med (Maywood); 2011 Jan; 236(1):30-5. PubMed ID: 21239733
[TBL] [Abstract][Full Text] [Related]
15. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
16. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
Chan RC; Xie Y
Oncol Rep; 2004 Aug; 12(2):435-42. PubMed ID: 15254713
[TBL] [Abstract][Full Text] [Related]
17. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.
Aishima S; Nishihara Y; Kuroda Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 May; 31(5):783-91. PubMed ID: 17460464
[TBL] [Abstract][Full Text] [Related]
18. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
19. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: an immunohistochemical study.
Apaydin R; Gürbüz Y; Bayramgürler D; Bilen N
Amyloid; 2005 Mar; 12(1):41-7. PubMed ID: 16076610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
